Fritz Bittenbender: guiding BIO through an America First era

Fritz Bittenbender is taking on the job of BIO board chair at time when the biotech industry is facing public policy challenges across the value chain, from threats to the NIH funding of biomedical research that fuels early stage companies to the specter of international reference pricing crushing profitability. 

BIO’s board broke the mold when it selected Bittenbender as chair. He is the first person to chair the organization who has never served as the CEO of a biotech company. ...